​

Autolus Therapeutics Ownership | Who Owns Autolus Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Autolus Therapeutics Ownership Summary

Autolus Therapeutics is owned by 63.13% institutional investors, 18.09% insiders, and 18.78% retail investors. Wellington management group llp is the largest institutional shareholder, holding 9.53% of AUTL shares. Syncona Ord is the top mutual fund, with 11.55% of its assets in Autolus Therapeutics shares.

AUTL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAutolus Therapeutics63.13%18.09%18.78%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Wellington management group llp25.35M9.53%$59.56M
Blackstone20.49M7.70%$48.14M
Syncona portfolio16.64M6.25%$39.11M
Fmr15.63M5.87%$36.74M
Deep track capital, lp14.22M5.34%$33.41M
Avoro capital advisors9.91M3.72%$23.29M
Armistice capital9.20M3.46%$21.62M
Tfg asset management gp8.25M3.10%$19.39M
Frazier life sciences management4.62M2.08%$16.09M
Blackrock4.44M2.00%$15.44M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Syncona portfolio16.64M73.83%$39.11M
Tfg asset management gp8.25M4.78%$19.39M
Great point partners3.01M3.33%$7.07M
Affinity asset advisors4.50M1.42%$10.57M
Deep track capital, lp14.22M1.25%$33.41M
Frazier life sciences management4.62M0.75%$16.09M
Healthinvest partners ab479.64K0.50%$1.06M
Dafna capital management586.67K0.35%$1.38M
Avoro capital advisors9.91M0.33%$23.29M
Armistice capital9.20M0.29%$21.62M

Top Buyers

HolderShares% AssetsChange
Candriam s.c.a.3.19M0.04%3.19M
Armistice capital9.20M0.29%2.33M
Morgan stanley2.90M0.00%2.21M
Axa1.82M0.01%1.82M
Wellington management group llp25.35M0.01%1.13M

Top Sellers

HolderShares% AssetsChange
Cormorant asset management, lp---6.62M
Paradigm biocapital advisors lp---6.43M
Perceptive advisors---4.33M
Deerfield management company, l.p. (series c)---3.64M
Adage capital partners gp---2.95M

New Positions

HolderShares% AssetsChangeValue
Candriam s.c.a.3.19M0.04%3.19M$7.50M
Axa1.82M0.01%1.82M$4.29M
Hennion & walsh asset management259.98K0.03%259.98K$610.95K
Point72 asset management247.09K0.00%247.09K$580.66K
Alps advisors215.19K0.00%215.19K$505.70K

Sold Out

HolderChange
Cornerstone planning group-100.00
Cubist systematic strategies-160.00
Carmichael hill & associates-254.00
Skopos labs-377.00
Lazard asset management-483.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202595-12.04%168,007,060-0.18%631.58%39-29.09%326.67%
Dec 31, 20241053.96%163,675,281-8.36%611.37%5450.00%30-16.67%
Sep 30, 202499-10.00%178,343,7070.33%671.05%36-33.33%3520.69%
Jun 30, 2024110-9.09%177,754,5781.37%801.28%54-23.94%297.41%
Mar 31, 202412123.47%175,349,12951.63%781.79%7136.54%2728.57%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Syncona Ord30.73M11.55%9.39M
Vanguard Health Care Inv19.36M7.27%-
FIAM Small Cap Core Composite3.17M1.19%-100.83K
FIAM Small Cap Core CIT Cl B3.14M1.18%-74.60K
AXA Framlington Health Fund - R Income3.13M1.17%-
Fidelity Small Cap Growth2.57M0.97%-
US Small-Cap Growth II Equity Comp2.24M0.84%-30.89K
T. Rowe Price New Horizons2.24M0.84%-30.23K
Wellington Global Hlthcr Eq USD G Ac2.21M0.83%-
International Biotechnology Ord1.94M0.73%-

AUTL Ownership FAQ

Who Owns Autolus Therapeutics?

Autolus Therapeutics shareholders are primarily institutional investors at 63.13%, followed by 18.09% insiders and 18.78% retail investors. The average institutional ownership in Autolus Therapeutics's industry, Biotech Stocks , is 63.96%, which Autolus Therapeutics falls below.

Who owns the most shares of Autolus Therapeutics?

Autolus Therapeutics’s largest shareholders are Wellington management group llp (25.35M shares, 9.53%), Blackstone (20.49M shares, 7.70%), and Syncona portfolio (16.64M shares, 6.25%). Together, they hold 23.48% of Autolus Therapeutics’s total shares outstanding.

Does Blackrock own Autolus Therapeutics?

Yes, BlackRock owns 2.00% of Autolus Therapeutics, totaling 4.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 15.44M$. In the last quarter, BlackRock increased its holdings by 380.18K shares, a 9.37% change.

Who is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested, with 73.83% of its assets in 16.64M Autolus Therapeutics shares, valued at 39.11M$.

Who is the top mutual fund holder of Autolus Therapeutics shares?

Syncona Ord is the top mutual fund holder of Autolus Therapeutics shares, with 11.55% of its total shares outstanding invested in 30.73M Autolus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools